Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
申请人:Nilsson Peter
公开号:US20120035217A1
公开(公告)日:2012-02-09
There is provided compounds of formula I,
wherein Y, ring A, D
1
, D
2a
, D
2b
, D
3
, L
1
, Y
1
, L
2
and Y
2
have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C
4
synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.
[EN] BIS AROMATIC COMPOUNDS FOR USE AS LTC4 SYNTHASE INHIBITORS<br/>[FR] COMPOSÉS BIS AROMATIQUES DESTINÉS À UTILISATION EN TANT QU'INHIBITEURS DE LTC4 SYNTHASE
申请人:BIOLIPOX AB
公开号:WO2010103297A3
公开(公告)日:2010-11-18
BIS AROMATIC COMPOUNDS FOR USE AS LTC4 SYNTHASE INHIBITORS
申请人:Biolipox AB
公开号:EP2406223A2
公开(公告)日:2012-01-18
[EN] BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION<br/>[FR] COMPOSÉS BIS-AROMATIQUES UTILISÉS POUR LES TRAITEMENTS ANTI-INFLAMMATOIRES
申请人:BIOLIPOX AB
公开号:WO2009030887A2
公开(公告)日:2009-03-12
There is provided compounds of formula (I): wherein Y, ring A, D1, D2, D3, L1, Y1, L2, Y2, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.
BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION
申请人:Pelcman Benjamin
公开号:US20100286215A1
公开(公告)日:2010-11-11
There is provided compounds of formula (I): wherein Y, ring A, D
1
, D
2
, D
3
, L
1
, Y
1
, L
2
, Y
2
, L
3
and Y
3
have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C
4
synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.